author-photo

Laurence Descamps

Novartis

2

Papers

9

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Trial in Progress: A Multicenter, Open-Label, Phase Ib/II Study to Determine the Dose and Safety of Asciminib in Pediatric Patients with Philadelphia Chromosome–Positive Chronic Myeloid Leukemia in Chronic Phase Treated with ≥1 Prior Tyrosine Kinase Inhibitor

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Long-Term Efficacy and Safety in COMFORT-II, a Phase 3 Study Comparing Ruxolitinib with Best Available Therapy for the Treatment of Myelofibrosis: 5-Year Final Study Results

2015 Blood
Show All
- Source
- Cite
- Save
Citations (9)